Oculomucocutaneous syndrome

From WikiMD's WELLNESSPEDIA


Oculomucocutaneous syndrome
Synonyms Stevens-Johnson syndrome, Lyell's syndrome
Pronounce N/A
Specialty N/A
Symptoms Conjunctivitis, keratitis, skin rash, oral ulcers
Complications Blindness, scarring, infection
Onset Sudden
Duration Variable
Types N/A
Causes Adverse drug reaction, infection
Risks Medication use, viral infections
Diagnosis Clinical examination, biopsy
Differential diagnosis Pemphigus vulgaris, toxic epidermal necrolysis
Prevention N/A
Treatment Corticosteroids, supportive care
Medication Antibiotics, analgesics
Prognosis Variable, can be severe
Frequency Rare
Deaths N/A


Oculomucocutaneous syndrome is a rare medical condition that affects the eyes, mucous membranes, and skin. It is often associated with the use of certain medications, particularly the drug practolol, a beta-blocker used to treat high blood pressure and heart conditions.

Symptoms[edit]

The symptoms of oculomucocutaneous syndrome can vary widely, but often include:

Causes[edit]

Oculomucocutaneous syndrome is most commonly associated with the use of the drug practolol. However, it can also occur as a result of other medications or underlying health conditions.

Diagnosis[edit]

Diagnosis of oculomucocutaneous syndrome is typically based on the presence of characteristic symptoms and a history of exposure to certain medications. Additional tests, such as a skin biopsy, may be performed to confirm the diagnosis.

Treatment[edit]

Treatment for oculomucocutaneous syndrome typically involves discontinuing the medication that is causing the condition. Additional treatments, such as topical steroids or artificial tears, may be used to manage symptoms.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.